Fig.1From: Treatment of MDA5-positive dermatomyositis complicated by gangrenous cholecystitis with tofacitinibClinical course. Skin lesions on face (a), palmar and opisthenar surface of hand with erythema (b) and ulcerations (c) before and after (d, e, f) treatment with tofacitinib for 6Â monthsBack to article page